SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 02/17/2026 at 19:00, 4 months 8 days ago

Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
Dépôt du Document d’Enregistrement Universel 2025 contenant le Rapport Financier Annuel et du « Form 20-F » américain par Sanofi. Consultation en ligne disponible

Rapport Financier Annuel Form 20-F Document D’enregistrement Universel Sanofi Consultation En Ligne
BRIEF

published on 02/17/2026 at 12:05, 4 months 8 days ago

Sanofi and Teva Report Positive Phase 2b Data for Duvakitug in IBD

Ulcerative Colitis Crohn’s Disease Phase 2b Study Duvakitug Sanofi-Teva Collaboration
BRIEF

published on 02/17/2026 at 12:05, 4 months 8 days ago

Sanofi and Teva: Promising advance in the treatment of inflammatory bowel diseases

Ulcerative Colitis Sanofi Teva Crohn's Disease Duvakitug
BRIEF

published on 02/17/2026 at 12:05, 4 months 8 days ago

Sanofi et Teva : Avancée prometteuse dans le traitement des maladies inflammatoires intestinales

Maladie De Crohn Sanofi Colite Ulcéreuse Teva Duvakitug
BRIEF

published on 02/17/2026 at 12:05, 4 months 8 days ago

Sanofi et Teva annoncent des résultats positifs de phase 2b pour Duvakitug dans les MICI

Maladie De Crohn Rectocolite Hémorragique Étude De Phase 2b Duvakitug Collaboration Sanofi-Teva
PRESS RELEASE

published on 02/17/2026 at 12:00, 4 months 8 days ago

Communiqué de presse : Les données de phase IIb de l’étude d’entretien sur le duvakitug de Sanofi et Teva ont démontré une efficacité durable cliniquement significative dans la colite ulcéreuse et la maladie de Crohn
Les données de phase IIb de l’étude d’entretien sur le duvakitug de Sanofi et Teva montrent une efficacité durable dans la colite ulcéreuse et la maladie de Crohn, renforçant le potentiel du traitement

Maladie De Crohn Sanofi Colite Ulcéreuse Teva Duvakitug
PRESS RELEASE

published on 02/17/2026 at 12:00, 4 months 8 days ago

Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
Sanofi and Teva's duvakitug phase 2b maintenance data show durable efficacy in ulcerative colitis and Crohn's disease. Results reinforce ongoing phase 3 programs in UC and CD

Ulcerative Colitis Sanofi Teva Crohn's Disease Duvakitug
BRIEF

published on 02/16/2026 at 07:05, 4 months 9 days ago

Beyfortus Shows Extended Benefits for Infants Against RSV

Infant Health Beyfortus Hospitalization Reduction RSV Immunization NIRSE-GAL Study
BRIEF

published on 02/16/2026 at 07:05, 4 months 9 days ago

Beyfortus présente des bénéfices prolongés chez les nourrissons contre le VRS

Beyfortus Réduction Des Hospitalisations Santé Infantile Vaccination Contre Le VRS Étude NIRSE-GAL
BRIEF

published on 02/16/2026 at 07:05, 4 months 9 days ago

Beyfortus prouve son efficacité au-delà de la première saison du VRS

Sanofi VRS Beyfortus Nourrissons Immunisation

Published on 06/25/2026 at 23:30, 2 minutes ago

Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 1 hour 2 minutes ago

Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 2 hours ago

BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 8 hours 2 minutes ago

Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/25/2026 at 15:00, 8 hours 32 minutes ago

Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend

View all ACCESSWIRE

Published on 06/25/2026 at 22:40, 52 minutes ago

DeFi Technologies Inc. Announces Extension of Proxy Voting Deadline for Upcoming Annual General and Special Meeting
Published on 06/25/2026 at 19:00, 4 hours 31 minutes ago

EQS-Adhoc: H&R GmbH & Co. KGaA resolves to prepare for the transition from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
Published on 06/25/2026 at 18:59, 4 hours 33 minutes ago

OHB Digital Connect completes upgrade of military ground stations
Published on 06/25/2026 at 18:40, 4 hours 52 minutes ago

Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias
Published on 06/25/2026 at 18:30, 5 hours 2 minutes ago

Delisting of Northern Data AG Shares - Munich Stock Exchange Decides on the Timeline

View all EQS

Published on 06/25/2026 at 18:45, 4 hours 47 minutes ago

Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 5 hours 2 minutes ago

Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 5 hours 42 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 06/25/2026 at 17:50, 5 hours 42 minutes ago

DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 06/25/2026 at 15:58, 7 hours 34 minutes ago

260625 BENETEAU Transactions sur actions propres

View all LES ECHOS COMFI WIRE

News